Top Stories
-
The Columbia community gathered in the Hudson Valley for the eighth annual Velocity: Columbia’s Ride to End Cancer. This year’s event raised more than $1 million and attracted nearly 600 participants.
Topic
-
Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
Topic
-
Physician-scientist Juanma Schvartzman is a firm believer that his curiosity-driven research on cell metabolism and its influence on cell identity will offer clues for better cancer treatments.
Topic
-
On Sunday, Oct. 6, cancer survivors, researchers, and physicians will cycle through the Hudson Valley to help Columbia solve cancer.
Topic
Latest News
- September 25, 2020
Velocity, Columbia’s annual fundraiser for cancer research, has changed this year, with participants cycling, running, and even sailing to support cancer research and care.
Topic
- August 26, 2020
The Herbert Irving Comprehensive Cancer Center has been redesignated as a Comprehensive Cancer Center by the NCI, the federal government’s principal agency for cancer research, care, and training.
Topic
- August 20, 2020
A study of cancer patients with COVID-19 finds mortality is significantly higher than in the general population and Black patients are half as likely to receive the antiviral remdesivir.
- July 31, 2020
A breast cancer patient explains how her treatment team unflinchingly continued her care during the COVID-19 pandemic.
Topic
- June 10, 2020
Compared to yearly screening, more frequent mammograms for women treated for early-stage breast cancer did not confer additional benefit, a study from Columbia University oncologists has found.
Topic
- April 20, 2020
Seizures are usually considered a side effect of brain cancer, but a new Columbia University study of mice suggests they may also fuel the further growth of brain tumors.
Topic
- April 9, 2020
Columbia University President Lee Bollinger announced the appointment of Anil Rustgi, MD, director of the Herbert Irving Comprehensive Cancer Center, as interim EVP and dean, effective July 1, 2020.
Topic
- April 3, 2020
Scientists at Columbia's Herbert Irving Comprehensive Cancer Center are using technologies developed to study cancer to look for drugs to treat COVID-19 and disarm the virus.
Topic
- April 2, 2020
In a new study of mice, Columbia researchers found that an experimental drug that breaks down an amino acid slows pancreatic tumor growth by causing ferroptosis, an unusual form of cell death.
- March 5, 2020
CancerFIT—a free exercise program at CUIMC for cancer patients and survivors—offers more than a physical workout, it also provides much-needed support and inspiration.
